STDs
Through Agency-Funded Contractors, NIAID Aims to Help Bring Infectious Disease Tests to Market
Premium
The Diagnostics Development Services program is, so far, being used to help point-of-care testing firm Fluxergy bring to market a test for sexually transmitted infections.
The Baltimore-based firm is developing multiplex molecular tests for sexually transmitted disease identification and drug susceptibility characterization.
CARB-X Awards $1M Each to Prompt Diagnostics, Fuse Diagnostics for Point-of-Care STI Tests
The funds will support the development of Prompt's test for drug resistant Neisseria gonorrhoeae and Fuse's test for N. gonorrhoeae and Chlamydia trachomatis.
Wastewater Surveillance of Chlamydia in Las Vegas Finds Peaks After Holidays, Major Sporting Events
The analysis, presented at ASM Microbe, also found that wastewater detection of the pathogen preceded increased numbers of clinically reported cases.
Binx Health Raises $65M in Series F Financing Round
The money raised in the Series F round will be used for commercial growth, sales support, and scaling up manufacturing.